Skip to main content
  • Editorial: Is “Non-Inferiority” Good Enough? Approaching the Asymptote in DES

    In this issue of CRM, de la Torre Hernandez et al. present data from a propensity-matched, controlled study to examine the safety and efficacy of the ihtDEStiny BD stent and delivery system compared to established everolimus and zotarolimus, biodurable polymer DES [  ].

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details